OTCPK:MEDOF (Germany)
Â
Akt. nach Kapitalherabsetzung
$
50
(0%)
10:08 PM EST
Business Description
Medios AG
ISIN : DE000A1MMCC8
Share Class Description:
MEDOF: Akt. nach KapitalherabsetzungTotal Employee Number:
982Compare
Compare
Traded in other countries / regions
ILM1.Germany0QB4.UKILM1.AustriaMEDOF.USA IPO Date
2018-08-28Description
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.5 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.36 | |||||
Debt-to-EBITDA | 2.29 | |||||
Interest Coverage | 2.32 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.31 | |||||
Beneish M-Score | -2.62 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.1 | |||||
3-Year EBITDA Growth Rate | 16.4 | |||||
3-Year EPS without NRI Growth Rate | -11.2 | |||||
3-Year FCF Growth Rate | 9.3 | |||||
3-Year Book Growth Rate | 3.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 36.69 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 2.52 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.92 | |||||
Quick Ratio | 1.47 | |||||
Cash Ratio | 0.49 | |||||
Days Inventory | 17.35 | |||||
Days Sales Outstanding | 26.84 | |||||
Days Payable | 19.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1 | |||||
Shareholder Yield % | 15.83 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 9.49 | |||||
Operating Margin % | 1.96 | |||||
Net Margin % | 0.66 | |||||
EBITDA Margin % | 3.89 | |||||
FCF Margin % | 2.43 | |||||
OCF Margin % | 2.88 | |||||
ROE % | 2.69 | |||||
ROA % | 1.51 | |||||
ROIC % | 3.14 | |||||
3-Year ROIIC % | 2.2 | |||||
ROC (Joel Greenblatt) % | 28.77 | |||||
ROCE % | 6.11 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 21.43 | |||||
Forward PE Ratio | 37.76 | |||||
PE Ratio without NRI | 14.63 | |||||
Shiller PE Ratio | 18.44 | |||||
Price-to-Owner-Earnings | 5.08 | |||||
PEG Ratio | 0.54 | |||||
PS Ratio | 0.14 | |||||
PB Ratio | 0.59 | |||||
Price-to-Tangible-Book | 7.43 | |||||
Price-to-Free-Cash-Flow | 5.81 | |||||
Price-to-Operating-Cash-Flow | 4.89 | |||||
EV-to-EBIT | 9.24 | |||||
EV-to-EBITDA | 5.01 | |||||
EV-to-Revenue | 0.19 | |||||
EV-to-FCF | 8.02 | |||||
Price-to-GF-Value | 0.75 | |||||
Price-to-Projected-FCF | 0.35 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.71 | |||||
Price-to-Graham-Number | 2.2 | |||||
Earnings Yield (Greenblatt) % | 10.82 | |||||
FCF Yield % | 16.84 | |||||
Forward Rate of Return (Yacktman) % | 34.72 |
Medios AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medios AG Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Guru Commentaries on OTCPK:MEDOF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Medios AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers